Search

1 to 9 of 9
Sort by

Blog Entry
Neurocritical Care Society Pharmacy Section Year in Review

By Jason Makii, PharmD, MBA, FCCM, FNCS, BCPS, BCCCP, Chair, Pharmacy Section Leadership Committee The pharmacy section continues to expand, and we have celebrated numerous successes this past year. Continued recruitment efforts have resulted in over 175 pharmacist members within the section,...


Blog Entry
Hypertonic Saline: Bolus or Continuous Infusion

By Brian Gilbert, PharmD, BCPS, BCCCP According to the Centers for Disease Control, it is estimated that over 1.5 million people sustain a traumatic brain injury (TBI) in the United States each year. 1 Treatment modalities listed by the Brain Trauma Foundation Guidelines (BTFG) include:...


Blog Entry
Invited Clinical Pharmacist (ICP) Program

The NCS Pharmacy Committee is excited to receive applications for the Invited Clinical Pharmacist (ICP) Program annually starting this November. The purpose of this program is to promote and increase the practice of neurocritical care pharmacy by sending qualified neurocritical care pharmacists...


Blog Entry
Hyperchloremia in the Neurocritically Ill Patient

By Caroline Der Nigoghossan, PharmD, BCCCP, and Shivani Ghoshal, MD (pictured) Intravenous crystalloid administration is one of the most common interventions performed in critically ill patients. However, during the last decade, a growing body of literature suggests potential harm with 0.9...


Blog Entry
Clinical Pharmacy Practice in Acute Neurological Illness in Germany

By Stefanie Amelung, RPh, Dipl.-Pharm. 1,2 (left), and Carina Hohmann, RPh, PhD 3 (right) Affiliations: 1 Pharmacy Department, Heidelberg University Hospital, Heidelberg, Germany 2 Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital,...


Blog Entry
Tenecteplase: Where Did We Come From? Where Do We Go?

By Kelsey M. Woods, PharmD, and Katleen Wyatt Chester, PharmD, BCGP, BCCCP Approved in 1996, alteplase has long been the standard of care for acute ischemic stroke (AIS) patients presenting within the window for treatment. Alteplase is also utilized for pulmonary embolism (PE), myocardial...


Blog Entry
Role of Dual Antiplatelet Therapy in Secondary Stroke Prevention

By Jason Kurian, PharmD and Salia Farrokh, PharmD, BCCCP For secondary stroke prevention, the 2013 American Heart Association (AHA) and American Stroke Association (ASA) joint guidelines recommend aspirin within 24 to 48 hours after stroke onset for most patients and state that the use of...


Blog Entry
Pharmacy Section: Year in Review

By Eljim P. Tesoro, PharmD, BCPS, Chair, Pharmacy Leadership Committee Another successful year is in the books for the Pharmacy Committee! Our recruitment efforts have resulted in over 160 pharmacists as members (an increase from last year), with nine new international pharmacists. Over 60...


Blog Entry
Clinical Pharmacy Practice in Chile: Focus in Neurocritical Care

By Marcial Cariqueo Arriagada, PharmD History Pharmacy schools in Chile introduced the role of the clinical pharmacist within the curriculum in the 1970s, based on the foundation work of Lisa Strand, PharmD. Since then, different subspecialties have been introduced within clinical...